The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...
Stocktwits on MSN
Pfizer CEO eyes big push towards obesity drug development in 2026 after $10B Metsera acquisition
Pfizer scrapped its own obesity drug candidate, Danuglipron, in early 2025, citing risks of liver enzyme elevations. ・The ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...
Dec 11 (Reuters) - AnaptysBio (ANAB.O), opens new tab said on Wednesday it would end the development of its eczema drug after it failed to meet the main and secondary goals of a mid-stage trial. The ...
Hosted on MSN
Why Tablet Hardness Matters in Drug Development
Produced in Partnership with ERWEKAReviewed by Emily MageeJan 6 2025 Tablets are the most common solid dosage form of medication by far, with over one trillion produced annually. 1 Tablets are mainly ...
The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of the alliance on the drug, a PD-L1x4-1BB bispecific antibody that was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback